Cardiac Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia — Target Definition, Dose Distribution, and Clinical Trajectory —
Circulation Journal · 02.07.2026
DOI: 10.1253/circj.cj-26-0551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Journal, erschienen am 02.07.2026. Verfasst von Shiro Nakahara und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Dokkyo Medical University Saitama Medical Center. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
lation by Cuculich et al., subsequent prospective studies, including the ENCORE-VT trial, have supported its N oninvasive cardiac radioablation has emerged as a treatment option for ventricular tachycardia (VT) refractory to antiarrhythmic drugs and catheter ablation.Since the landmark proof-of-concept report of catheter-free, electrophysiology-guided cardiac radioab-Article p ????
Autor:innen und Institutionen
- Department of Cardiology, Dokkyo Medical University Saitama Medical Center.
Zitieren
APA
Nakahara, S., & Taguchi, I. (2026). Cardiac Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia — Target Definition, Dose Distribution, and Clinical Trajectory —. Circulation Journal. https://doi.org/10.1253/circj.cj-26-0551
Vancouver
Nakahara S, Taguchi I. Cardiac Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia — Target Definition, Dose Distribution, and Clinical Trajectory —. Circulation Journal. 2026. doi:10.1253/circj.cj-26-0551
BibTeX
@article{Nakahara2026,
author = {Nakahara, Shiro and Taguchi, Isao},
title = {Cardiac Stereotactic Body Radiotherapy for Refractory Ventricular Tachycardia — Target Definition, Dose Distribution, and Clinical Trajectory —},
journal = {Circulation Journal},
year = {2026},
doi = {10.1253/circj.cj-26-0551}
}
EUVIMED